 |
|
A Comparison of Some newer Anticoagulants
LAUDER BRUNTON, M.D.;
LOUIS LOWENSTEIN, M.D.;
LORNE SHAPIRO, M.D.
AMA Arch Surg. 1956;72(1):153-159.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
For the past two years the hematology service of the Royal Victoria Hospital has been using several different anticoagulants in an attempt to determine which, if any, is the best for routine use and which are most suitable under special conditions. It is the purpose of this paper to describe our experience with the anticoagulants cyclocumarol, 3-( 1'-phenylpropyl)-oxycoumarin (Marcumar), and warfarin sodium * and to compare the action of these drugs with each other and with bishydroxycoumarin (Dicoumarol). Experience with cyclocumarol at the Royal Victoria Hospital has been reported elsewhere.
METHODS
The selection of cases and the application of anticoagulant therapy have been discussed in detail in previous papers. In brief, the patients utilized for these studies were those referred to the hematology service for anticoagulant therapy, and no special selection was made. The majority of patients suffered from myocardial infarction or venous thrombosis.
In most cases the anticoagulant therapy
. . . [Full Text PDF of this Article]
Author Affiliations
Montreal, Canada
From the Haematology Service, Department of Medicine, Royal Victoria Hospital.
Footnotes
Submitted for publication Aug. 22, 1955.
This work was supported in part by Abbott Laboratories and by Hoffmann-LaRoche, Inc.
Presented at the Meeting of the International Society of Angiology, Atlantic City, N. J., June 4, 1955.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
